ArticleThe American journal of tropical medicine and hygiene2017
Elimination of Kala-Azar from the Southeast Asia Region.
Article in The American journal of tropical medicine and hygiene, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Prevalence and associated risk factors of human leishmaniasis in sub-Saharan Africa: an umbrella review.BMC infectious diseases · 2025Pooled it
- The impact of leishmaniasis on mental health and psychosocial well-being: A systematic review.PloS one · 2019Pooled it
- Pooled it
- Decision-making for indoor residual spraying in the post-elimination phase of visceral leishmaniasis in Nepal.PLoS neglected tropical diseases · 2026Article
- Application of ddPCR for diagnosis and treatment monitoring of visceral leishmaniasis patients: addition of an ultrasensitive tool to the diagnostic arsenal.Microbiology spectrum · 2026Article
- A Forgotten Foe Returns: The Diagnostic Odyssey of Kala-Azar Masquerading as Myelodysplastic Syndrome in a Post-Elimination Era.Clinical case reports · 2025Article
- The story of elimination of visceral leishmaniasis (kala-azar) in India-Challenges towards sustainment.PLoS neglected tropical diseases · 2025Review
- Association of Post Kala-Azar Dermal Leishmaniasis pathogenesis with prolonged sunlight (ultraviolet radiations) exposure in VL endemic population of Bihar.Scientific reports · 2025Article
- Kala-azar elimination in India: reflections on success and sustainability.International health · 2025Article
- Advances and Challenges in the Diagnosis of Leishmaniasis.Molecular diagnosis & therapy · 2025Review
- Active Community-Based Case Finding of Endemic Leishmaniasis in West Bengal, India.Journal of epidemiology and global health · 2024Article
- Challenges for maintaining post elimination phase of visceral leishmaniasis control programme in India: A field-based study.PLoS neglected tropical diseases · 2024Article
- Assessment of the impact of implementation research on the Visceral Leishmaniasis (VL) elimination efforts in Nepal.PLoS neglected tropical diseases · 2023Review
- Response to Visceral Leishmaniasis Cases through Active Case Detection and Vector Control in Low-Endemic Hilly Districts of Nepal.The American journal of tropical medicine and hygiene · 2022Article
- The increasing incidence of visceral leishmaniasis relapse in South Sudan: A retrospective analysis of field patient data from 2001-2018.PLoS neglected tropical diseases · 2022Article
- Bioprospecting marine actinomycetes for antileishmanial drugs: current perspectives and future prospects.Heliyon · 2021Review
- Vulnerabilities to and the Socioeconomic and Psychosocial Impacts of the Leishmaniases: A Review.Research and reports in tropical medicine · 2021Review
- Is Leishmaniasis donovani elimination feasible in Bhutan? A review of current prevention and control mechanisms in Bhutan.Bhutan health journal · 2020Article
- Synthesis and antileishmanial effect of a few cyclic and non-cyclicResearch in pharmaceutical sciences · 2020Article
- Role of female community health volunteers for visceral leishmaniasis detection and vector surveillance in Nepal.Health promotion perspectives · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
AbstractVisceral leishmaniasis (VL), popularly known as kala-azar, is essentially a disease of poverty. Kala-azar is caused by a parasite,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.